S Theiner, M Lacková, R Russo, Z Dvořák, B Lipový, M Knoz
{"title":"Comparison of lymphovenous anastomosis and vascularized lymph node transfer in lymphedema treatment - a literature review.","authors":"S Theiner, M Lacková, R Russo, Z Dvořák, B Lipový, M Knoz","doi":"10.48095/ccachp202542","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are both accepted microsurgical treatment options for lymphedema. This article summarises and analyses recent data on outcomes associated with LVA and VLNT for lymphedema treatment at varying degrees of severity.</p><p><strong>Methods: </strong>Literature research was conducted in the PubMed and Embase Ovid database to extract articles published through March 2024. The included studies report data on objective and subjective improvement in lymphedema after physiological surgical procedures as LVA and VLNT. Extracted data comprised number of patients, affected limbs, staging of the disease, duration of the follow up period, objective and subjective improvement and percentage of discontinuation of compression garments.</p><p><strong>Results: </strong>A total of 23 articles were included in this article, representing 1,944 patients suffering from either primary or secondary lymphedema. The lymphedema stages were classified by classification of International Society of Lymphedema (ISL stage) or Campisi stage and range from stage I to III, as well as prophylactic indication for surgery. The follow-up duration ranged from 3 months to 8 years. Objective improvement was achieved in 82.76-100% and measured in circumferential reduction rate and reduction of cellulitis episodes. In 80-100% of the patient's subjective improvement was seen, which was measured in quality of life and personal feedback. The percentage of patients able to discontinue the use of compression garments ranges from 0 to 100%, while others were able to reduce the total time of wearing.</p><p><strong>Conclusion: </strong>LVA and VLNT are both safe and effective techniques for the surgical treatment of lymphedema in several stages. LVA should be preferred if the lymph vessels preserved its patency, otherwise VLNT might be the therapy of choice. Combinations of various procedures with an appropriate postoperative treatment plan might lead to improved patient outcomes.</p>","PeriodicalId":7098,"journal":{"name":"Acta chirurgiae plasticae","volume":"67 1","pages":"42-54"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta chirurgiae plasticae","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/ccachp202542","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) are both accepted microsurgical treatment options for lymphedema. This article summarises and analyses recent data on outcomes associated with LVA and VLNT for lymphedema treatment at varying degrees of severity.
Methods: Literature research was conducted in the PubMed and Embase Ovid database to extract articles published through March 2024. The included studies report data on objective and subjective improvement in lymphedema after physiological surgical procedures as LVA and VLNT. Extracted data comprised number of patients, affected limbs, staging of the disease, duration of the follow up period, objective and subjective improvement and percentage of discontinuation of compression garments.
Results: A total of 23 articles were included in this article, representing 1,944 patients suffering from either primary or secondary lymphedema. The lymphedema stages were classified by classification of International Society of Lymphedema (ISL stage) or Campisi stage and range from stage I to III, as well as prophylactic indication for surgery. The follow-up duration ranged from 3 months to 8 years. Objective improvement was achieved in 82.76-100% and measured in circumferential reduction rate and reduction of cellulitis episodes. In 80-100% of the patient's subjective improvement was seen, which was measured in quality of life and personal feedback. The percentage of patients able to discontinue the use of compression garments ranges from 0 to 100%, while others were able to reduce the total time of wearing.
Conclusion: LVA and VLNT are both safe and effective techniques for the surgical treatment of lymphedema in several stages. LVA should be preferred if the lymph vessels preserved its patency, otherwise VLNT might be the therapy of choice. Combinations of various procedures with an appropriate postoperative treatment plan might lead to improved patient outcomes.
背景:淋巴静脉吻合(LVA)和血管化淋巴结转移(VLNT)都是淋巴水肿的显微外科治疗选择。本文总结和分析了最近关于LVA和VLNT治疗不同严重程度淋巴水肿的相关结果的数据。方法:在PubMed和Embase Ovid数据库中进行文献研究,提取截止2024年3月发表的文章。纳入的研究报告了生理手术(如LVA和VLNT)后淋巴水肿的客观和主观改善数据。提取的数据包括患者人数、受影响肢体、疾病分期、随访时间、客观和主观改善以及停止使用压缩服的百分比。结果:本文共纳入23篇文献,共纳入1,944例原发性或继发性淋巴水肿患者。淋巴水肿分期按照国际淋巴水肿学会(International Society of lymphodema, ISL分期)或Campisi分期进行分级,从I期到III期,以及手术的预防指征。随访时间为3个月至8年。目标改善率为82.76-100%,测量了周向减少率和蜂窝织炎发作的减少。在80-100%的患者主观改善被看到,这是衡量生活质量和个人反馈。能够停止使用压缩服的患者百分比从0到100%不等,而其他患者能够减少穿着的总时间。结论:LVA和VLNT是分阶段治疗淋巴水肿的安全有效的手术方法。如果淋巴管保持通畅,应首选LVA,否则可能选择VLNT。各种手术与适当的术后治疗计划的结合可能会改善患者的预后。